心脏再同步疗法:重新考虑其本质作为治疗心力衰竭中电动失同的治疗方法
Michio Ogano1, Yu-Ki Iwasaki2, Jun Tanabe1
1Department of Cardiovascular Medicine Shizuoka Medical Center Shimizu Japan.
Journal of arrhythmia
|January 12, 2026
概括
心脏再同步疗法 (CRT) 解决了心力衰竭 (HF) 中的电失同. 早期CRT植入对于管理HF,预防重塑和优化治疗以获得更好的患者结果至关重要.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
背景情况:
- 心力衰竭 (HF) 往往是由电动失调驱动的.
- CRT的有效性取决于评估异步的质量 (QRS形态) 和数量 (QRS持续时间).
研究的目的:
- 强调个性化患者选择CRT的重要性.
- 强调CRT在预防心脏重塑和优化医疗治疗中的作用.
主要方法:
- 审查目前对CRT机制和患者选择标准的理解.
- 早期CRT植入与延迟干预的影响分析.
主要成果:
- 在心力衰竭中,CRT有效地准电动失调.
- 基于异步特征的个性化患者选择是CRT有效性的关键.
结论:
- 早期的CRT植入对于全面的心力衰竭管理至关重要.
- 应将CRT整合到适合患者的标准HF护理中,以防止不可逆转的重塑.
相关概念视频
Cardiomyopathy II: Dilated Cardiomyopathy
455
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
455
Dysrhythmias VI: Management of Dysrhythmias
424
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
424
Heart Failure VI: Adjunct Therapies
245
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
245
Disturbances in Heart Rhythm
2.5K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
2.5K
Dysrhythmias V: Evaluating Dysrhythmias
317
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
317
Cardiomyopathy V: Interprofessional Care
326
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
326


